Know Cancer

or
forgot password

A Pilot Trial of Pre-Operative Chemoradiotherapy Using Capecitabine (Xelodaâ), External Beam Radiation and Cetuximab (Erbitux®) Followed by Definitive Surgery in Patients With Localized (Non-Metastatic) Rectal Cancer


N/A
14 Years
85 Years
Open (Enrolling)
Both
Localized Non-Metastatic Rectal Cancer

Thank you

Trial Information

A Pilot Trial of Pre-Operative Chemoradiotherapy Using Capecitabine (Xelodaâ), External Beam Radiation and Cetuximab (Erbitux®) Followed by Definitive Surgery in Patients With Localized (Non-Metastatic) Rectal Cancer


A Pilot Trial of Pre-Operative Chemoradiotherapy Using Capecitabine (Xelodaâ), External Beam
Radiation and Cetuximab (Erbitux®) Followed by Definitive Surgery in Patients With Localized
(Non-Metastatic) Rectal Cancer


Inclusion Criteria:



- Patients with Localized Non-Metastatic Rectal Cancer

Exclusion Criteria:

- Patients with diagnosis other than Localized Non-Metastatic Rectal Cancer

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Cross-Sectional

Principal Investigator

Shouki Bazarbashi, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

KFSH & RC

Authority:

United States: Institutional Review Board

Study ID:

RAC# 2071-051

NCT ID:

NCT01310985

Start Date:

March 2008

Completion Date:

Related Keywords:

  • Localized Non-Metastatic Rectal Cancer
  • Rectal Cancer
  • Rectal Neoplasms

Name

Location